Stephen Barat - 02 Feb 2023 Form 3 Insider Report for HTG MOLECULAR DIAGNOSTICS, INC (HTGMQ)

Role: Senior VP of Therapeutics
Signature: /s/ Shaun D. McMeans, Attorney-in-Fact
Issuer symbol: HTGMQ
Transactions as of: 02 Feb 2023
Transactions value $: $0
Form type: 3
Filing time: 10 Feb 2023, 15:34:09 UTC
Next filing: 07 Apr 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	HTGMQ	Common Stock						1,361	02 Feb 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	HTGMQ	Stock Option (right to buy)							02 Feb 2023	Common Stock	4,166	$62.41	Direct	F1
holding	HTGMQ	Stock Option (right to buy)							02 Feb 2023	Common Stock	2,083	$11.28	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	1/4th of the shares vested on the one-year anniversary of October 1, 2021 (the "Vesting Commencement Date"); the balance of the shares vest in a series of twelve (12) successive equal quarterly installments on the last day of each calendar quarter, commencing with the last day of the calendar quarter first occurring after the one-year anniversary of the Vesting Commencement Date.
F2	The shares vest in a series of eight (8) successive equal quarterly installments on the last day of each calendar quarter, with the first such installment occurring on September 30, 2022.